There's Now a $1-a-Pill Competitor to Pharma CEO Martin Shkreli's $750-a-Pill Drug

Business Insider
Oct. 23, 2015

Almost a month after word got out that drug-company CEO Martin Shkreli had jacked up the price of a critical drug by more than 5,000%, a different kind of pharma company has stepped up to provide a cheaper alternative.

Read More













All original InformationLiberation articles CC 4.0



About - Privacy Policy